(Q43276156)

18 November 2017

title

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy (English)

1 reference

18 November 2017

2

1 reference

18 November 2017

Cesare Cozzarini

7

0 references

Nadia Di Muzio

8

object named as

Nadia Di Muzio

1 reference

18 November 2017

author name string

Giampiero Giovacchini

1

1 reference

18 November 2017

Elisa Coradeschi

3

1 reference

18 November 2017

Valentino Bettinardi

4

1 reference

18 November 2017

Luigi Gianolli

5

1 reference

18 November 2017

Vincenzo Scattoni

6

1 reference

18 November 2017

Patrizio Rigatti

9

1 reference

18 November 2017

Ferruccio Fazio

10

1 reference

18 November 2017

Cristina Messa

11

1 reference

18 November 2017

publication date

15 September 2009

1 reference

18 November 2017

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

18 November 2017

volume

37

1 reference

18 November 2017

issue

2

1 reference

18 November 2017

page(s)

301-309

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-009-1253-3

18 November 2017

exact match

0 references

cites work

Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1253-3

Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.

21 January 2018

1 reference

12 December 2020

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

1 reference

12 December 2020

Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells

1 reference

12 December 2020

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

1 reference

12 December 2020

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

1 reference

12 December 2020

Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer

1 reference

12 December 2020

Fluorocholine PET/CT in patients with prostate cancer: initial experience

1 reference

12 December 2020

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer

1 reference

12 December 2020

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

1 reference

12 December 2020

Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging

1 reference

12 December 2020

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

1 reference

12 December 2020

Experience with carbon-11 choline positron emission tomography in prostate carcinoma

1 reference

12 December 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

12 December 2020

Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections.

1 reference

12 December 2020

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers

1 reference

12 December 2020

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy

1 reference

12 December 2020

Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

1 reference

12 December 2020

PET/CT in diagnostic oncology.

1 reference

12 December 2020

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.

1 reference

12 December 2020

Do younger men have better biochemical outcomes after radical prostatectomy?

1 reference

12 December 2020

Impact of acquisition geometry, image processing, and patient size on lesion detection in whole-body 18F-FDG PET.

1 reference

12 December 2020

Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal

1 reference

12 December 2020

[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

1 reference

12 December 2020

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

1 reference

12 December 2020

Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer

1 reference

12 December 2020

Multinomial goodness-of-fit tests for logistic regression models

1 reference

12 December 2020

Patient age as a prognostic factor in prostate cancer

1 reference

12 December 2020

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

1 reference

12 December 2020

Performance evaluation of the new whole-body PET/CT scanner: Discovery ST.

1 reference

12 December 2020

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

1 reference

12 December 2020

Optimization of injected dose based on noise equivalent count rates for 2- and 3-dimensional whole-body PET.

1 reference

12 December 2020

Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer

1 reference

12 December 2020

Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner.

1 reference

12 December 2020

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

1 reference

12 December 2020

Age as a prognostic factor for disease recurrence after radical prostatectomy

1 reference

12 December 2020

Risk of prostate carcinoma death in patients with lymph node metastasis

1 reference

12 December 2020

Goodness-of-fit processes for logistic regression: simulation results.

1 reference

12 December 2020

10.1007/S00259-009-1253-3

Identifiers

DOI

1 reference

18 November 2017

1 reference